Its also obvious some posts here are from newbies.
OSP have stepped up their sales coverage like never before in the last year. This all costs money.
Previously, only a handful of states in the US were being sold into. But now they have worldwide coverage coming out of COVID, of an FDA approved product that has no substitute - see economics 101.
On a comparative basis, this quarter is excellent in the costs history of OSP. Further, they are doing it during COVID.
Biden wants all Americans vaccinated before the 4th July. One quarter to go before hospitals have fully recovered.
Hospitals obviously like the product if sales are increasing at this rate during the pandemic.
If you want costs reduced further, try lawnmower or hamburger shops. Here the whinge is validated.
This is a product that has no FDA approved substitute, provides revenue + $17.7 million in the bank.
Above is my opinion only and not financial advice.
